The cutaneous microbiota plays an essential role in skin health.

Consequently, it becomes necessary to address the evaluation of cosmetic impact and medical device on skin microbiota:

  • Either to avoid any skin microbiota imbalance,
  • Or, on the contrary, to reestablish the balance if any dysbiosis (atopy, dandruff, acne …).

 

Intertek conducts clinical studies on healthy volunteers or on volunteers suffering from a cutaneous pathology in order to analyze this impact.

 

Intertek offers 3 levels of investigation:

 

Intertek’s expertise for Microbiota:

  • A suitable recruitment of volunteers,
  • Samples management expertise: sampling and transport,
  • Analysis and results interpretation by skin microbiome experts team.

Intertek France – Clinical Research Department
48 Rue de la Colonie
75013 Paris – France
Email: france@intertek.com
Phone: +33 (0)2.78.94.03.78

http://www.intertek-france.com/etudes-cliniques

Recent Posts

Skinobs revamps We Are Testing® with a bold new identity

Skinobs Revamps “We Are Testing” with a bold new identity and website ahead of NYSCC…

We Are Testing® at NYSCC Suppliers’ Day 2025

👉 The Skinobs team will be delighted to welcome you booth 857, to talk with…

Pollution, a relevant exposome factor in skin aging and the role of multi-benefit photoprotection via ACTAS

J. Santamaria, Y. Gilaberte, L. Prudkin, J. Piquero-Casals 11 March 2025 Skin aging is a…